Ameriprise Financial Inc Annexon, Inc. Transaction History

Ameriprise Financial Inc

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$22.0 - $35.01 $5.44 Million - $8.65 Million	-247,071 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$20.81 - $30.55 $967,456 - $1.42 Million	46,490 Added 23.18%	247,071 $6.19 Million
Q3 2020 Nov 16, 2020	BUY	$17.5 - $30.23 $3.51 Million - $6.06 Million	200,581 New	200,581 $6.06 Million

156

101M

3.73M

1.3M

Ticker ANNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,617,700
Market Cap $335M
Description
Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated n...

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

Stay updated on Ameriprise Financial Inc with notifications on news.